Biogen Inc (NASDAQ:BIIB)

280.21
Delayed Data
As of Jul 08
 +11.84 / +4.41%
Today’s Change
215.78
Today|||52-Week Range
374.99
-5.57%
Year-to-Date
Why Biogen Stock Jumped Today
Jul 08 / MotleyFool.com - Paid Partner Content
Forget Vertex, Biogen Is a Better Value Stock
Jul 01 / MotleyFool.com - Paid Partner Content
Biogen Shares Spike on Alzheimer's Update
Jul 08 / MotleyFool.com - Paid Partner Content
Should You Buy These 3 Stocks Tackling Alzheimer's Disease?
Jun 29 / MotleyFool.com - Paid Partner Content
Biogen Lifts Nasdaq to Near-Record; JD.com Leads China Internet Stocks Higher
Jul 08 / MotleyFool.com - Paid Partner Content
Better Coronavirus Stock: Biogen or BioNTech?
Jun 27 / MotleyFool.com - Paid Partner Content
Better Buy: AbbVie vs. Biogen
Jul 08 / MotleyFool.com - Paid Partner Content
Is This Bargain Biotech Stock a Treasure or a Trap?
Jun 27 / MotleyFool.com - Paid Partner Content
Why Biogen Shares Fell 12.9% in June
Jul 02 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close268.35
Today’s open294.32
Day’s range278.17 - 294.99
Volume3,258,221
Average volume (3 months)2,011,792
Market cap$43.3B
Data as of 4:34pm ET, 07/08/2020

Growth & Valuation

Earnings growth (last year)+45.55%
Earnings growth (this year)-1.60%
Earnings growth (next 5 years)+2.00%
Revenue growth (last year)+5.49%
P/E ratio8.7
Price/Sales4.37
Price/Book3.46

Competitors

 Today’s
change
Today’s
% change
ILMNIllumina Inc-2.25-0.60%
MRNAModerna Inc+0.49+0.80%
BMRNBiomarin Pharmaceuti...+0.75+0.59%
EXASExact Sciences Corp+5.36+6.21%
Data as of 4:00pm ET, 07/08/2020

Financials

Next reporting dateJuly 28, 2020
EPS forecast (this quarter)$8.01
Annual revenue (last year)$12.7B
Annual profit (last year)$5.9B
Net profit margin46.32%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Cambridge, Massachusetts

Forecasts